CORONAVIRUS
LIVE UPDATES

Optimism prevails at Baird Global Healthcare ConferenceSARS-CoV-2 as invisible threat: Mitigating aerosols in dental clinicsEnglish dentists given updated guidance on treatment during pandemicInterview: Prof. Richard Watt on COVID-19 and the potential for dental reformADF congress 2020 cancelledDentists in Scotland voice concerns over expired personal protective equipmentInternational College of Dentists launches online education initiativeEuroPerio10 to take place in 2022Interview: Prof. David Denning discusses DenScreen and antibody testingParadigm shift in dentistry: Dr Pallavi Patil on practicing during the pandemic

Visit microsite

ACTEON Company Profile

ePaper

ePaper editions are exact digital copies of the DTI print publications. All publications that include information about ACTEON’s products can be found here.

digital international No. 2, 2020

implants international No. 2, 2020

digital international No. 1, 2020

cosmetic dentistry Turkey No. 2, 2019

roots Turkey No. 2, 2019

implants Poland No. 4, 2019

today ADF Paris Nov. 29, 2019

today ADF Paris Nov. 28, 2019

Zahnärztliche Assistenz No. 2, 2019

CAD/CAM international No. 4, 2019

today EAO Lisbon 26 September 2019

today CEDE Poznań 2019

1 2 … 6 7 Older Posts

Everything ACTEON

17 avenue Gustave Eiffel, BP 30216
MERIGNAC cedex, 33708
France
Tel.: +33 (0) 556 34 06 07
Fax: +33 (0) 556 34 92 92

www.acteongroup.com
info@acteongroup.com

NewsView All

Michael Rynerson appointed CEO of ACTEON

June 22, 2020 | Events, Interviews, News

BORDEAUX, France: Michael Rynerson is the new CEO of the dental and medical technology and device manufacturer ACTEON, which is headquartered in France. The supervisory board of Finapolline, the holding company of ACTEON, appointed him to the position effective on 1 June. The chairman of the supervisory board commented that Rynerson has over 25 years of experience, most notably in the dental industry, and possesses the skills to lead the company out of the current health and economic crisis and through its next phase of development.

EXPASYL EXACT: Effective and atraumatic gingival retraction

February 21, 2020 | Events, Interviews, News

CHICAGO, U.S.: Few products have had such a positive effect on dentistry as the EXPASYL gingival retraction paste from ACTEON. After 20 years of clinical research and efficacy, EXPASYL continues to be the choice of many dentists for tissue management during restorative and cosmetic dental treatment. Now, EXPASYL EXACT is available on the market. It offers the same results in the exact amount needed in a cost-effective, single-use capsule that can be used in any composite gun. This means that there will be no more wasted material and there is no need to purchase expensive application guns. At the 155th Chicago Dental Society Midwinter Meeting currently being held in Chicago, interested parties can view the new product at the ACTEON booth (#2811).

It’s time for minimally invasive solutions with ACTEON imaging systems

February 03, 2020 | Events, Interviews, News

DUBAI, UAE: The innovation offered by X-MIND trium and X-MIND prime confirms ACTEON as a leader in designing less invasive, less traumatic and the most technologically advanced dental imaging solutions. The company is showcasing both devices at AEEDC 2020 and invites participants to learn more at the ACTEON booth (#6 G01).

WebinarsView All